Trial
NCT01245101
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
Merck Sharp & Dohme LLC
Condition
HIV
Intervention
Raltegravir
Why stopped
Poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-23